Related Experiment Video
Updated: Mar 24, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy
Daryl Schantz1,2, Lee Benson1, Jonathan Windram3
1Department of Paediatrics, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Insights
Children and adolescents with hypertrophic cardiomyopathy (HCM) have significantly longer mitral valve leaflets compared to healthy children. This mitral valve elongation in HCM is not linked to outflow obstruction.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) involves cardiac structural abnormalities beyond myocardial thickening.
- Adults with HCM exhibit longer mitral valve leaflets compared to controls.
- Elongated mitral valve leaflets may be a characteristic feature of HCM.
Purpose of the Study:
- To investigate if pediatric and adolescent patients with HCM also present with elongated mitral valve leaflets.
- To compare mitral valve leaflet dimensions in pediatric HCM patients versus healthy controls.
Main Methods:
- Retrospective review of clinical and echocardiographic data from 46 pediatric HCM patients.
- Evaluation of cardiac magnetic resonance imaging studies.
- Comparison of anterior and posterior mitral valve leaflet lengths between HCM patients and 20 healthy controls.
Main Results:
- Patients with HCM showed significantly longer anterior mitral valve leaflets (28.4 ± 4.9 mm) than controls (25.2 ± 3.6 mm, p=0.013).
- Posterior mitral valve leaflets were also longer in the HCM group (16.3 ± 3.0 mm) compared to controls (13.1 ± 2.3 mm, p<0.0001).
- No correlation was found between leaflet length and left ventricular outflow tract gradient or systolic anterior motion.
Conclusions:
- Pediatric and adolescent patients with HCM possess abnormally elongated mitral valve leaflets.
- Mitral valve elongation in pediatric HCM does not appear to cause or result from left ventricular outflow obstruction.
- The underlying mechanism for mitral valve elongation in HCM remains unclear and seems independent of hemodynamic factors.
Abstract:
The hearts of patients with hypertrophic cardiomyopathy (HCM) show structural abnormalities other than isolated wall thickening. Recently, adult HCM patients have been found to have longer mitral valve leaflets than control subjects. The aim of the current study was to assess whether children and adolescents with HCM have similar measureable differences in mitral valve leaflet dimensions when compared to a healthy control group. Clinical and echocardiographic data from 46 children with myocardial hypertrophy and a phenotype and/or genotype consistent with sarcomeric HCM were reviewed. Cardiac magnetic resonance imaging studies were evaluated. The anterior and posterior mitral valve leaflet lengths and myocardial structure were compared to 20 healthy controls. The anterior mitral valve was longer in the HCM group than in the control group (28.4 ± 4.9 vs. 25.2 ± 3.6 mm in control patients, p = 0.013) as was the posterior mitral valve leaflet (16.3 ± 3.0 vs. 13.1 ± 2.3 mm for controls <0.0001). There was no correlation between the resting left ventricular outflow tract gradient and anterior mitral valve leaflet length, nor was the anterior mitral valve leaflet longer in those with systolic anterior motion of the mitral valve compared to those without (28.9 ± 6.1 vs. 28.1 ± 4.5 mm, p = 0.61). Children and adolescents with HCM have abnormally long mitral valve leaflets when compared with healthy control subjects. These abnormalities do not appear to result in, or be due to, obstruction to left ventricular outflow. The mechanism of this mitral valve elongation is not clear but appears to be independent of hemodynamic disturbances.
More Related Videos
Related Concept Videos
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction

